You are seeing Ask web results for restenosis.
|
Encyclopedia: Restenosis
Restenosis literally means the reoccurrence of stenosis. This is usually restenosis of an artery, or other blood vessel, but possibly any hollow organ that has been "unblocked". This term is common in...
en.wikipedia.org/wiki/Restenosis |
|
Aug 20, 2004 Restenosis remains a challenge after angioplasty and stenting.
|
|
|
Restenosis - the re-narrowing of a coronary artery after it has been treated with angioplasty or stenting - remains a major problem to patients and their doctors. Read about restenosis and what is being done about it here...
|
|
|
The use of stents has lowered this rate of recurrence or restenosis, and new types of devices that release clot-deterring medicine or even certain forms of radiation have been developed in the hopes of reducing this problem even further.
|
|
|
What does restenosis mean? Why does in-stent restenosis happen? Who is at high risk for in-stent restenosis?
|
|
|
Context Although vascular brachytherapy is the only approved therapy for restenosis following bare-metal stent implantation, drug-eluting stents are now being used. Data on the relative merits of each are limited.
|
|
|
Objective To determine the safety and efficacy of the sirolimus-eluting stent compared with vascular brachytherapy for the treatment of patients with restenosis within a bare-metal stent.
|
|
|
; Stenosis and Restenosis of Coronary Arteries; What are stenosis and restenosis? One way to help prevent restenosis is by using stents. A stent is a wire mesh tube used to prop open an artery after angioplasty. Restenosis is less common in stented arteries. Studies are under way using stents covered with drugs...
|
|
|
Definition of restenosis at Dictionary.com with free online dictionary, pronunciation, synonyms, and translation. Word of the Day and Crossword Puzzles. restenosis - 2 dictionary results...
|
|
|
AIMS: In patients with in-stent restenosis (ISR) several anatomic subgroups have been identified. ISR affecting the stent edge (EDG) is a poorly characterised subgroup with undefined therapeutic implications. We sought to determine the implications of ISR affecting the stent EDG.
|
